共 20 条
[1]
Appelbaum F.R., Storb B., Ramberg R.E., Shulman H.M., Buckner C.D., Clift R.A., Deeg H.J., Fefer A., Sanders J., Self S., Swiger J., Stewart P., Sullivan K., Witherspoon R., Thomas E.D., Treatment of preleukemic syndromes with marrow transplantation, Blood, 69, pp. 92-96, (1987)
[2]
Lai P.H., Everett R., Wang F.F., Arakawa T., Goldwasser E., Structural characterization of human erythropoietin, J. Biol. Chem., 261, pp. 3116-3121, (1986)
[3]
Eschbach J.W., The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin, Kidney Int., 35, pp. 134-148, (1989)
[4]
Ludwig H., Fritz E., Kotzman H., Hocker F., Gisslinger H., Barnas U., Erythropoietin treatment of anemia associated with multiple myeloma, N. Eng. J. Med., 31, pp. 1693-1699, (1990)
[5]
Aoki I., Chikazawa H., Higashi K., Ishikawa K., In vitro effects of high titers of recombinant human erythropoietin on the bone marrow erythroid progenitors in patients with aplastic anemia, Jpn. J. Clin. Hematol., 30, pp. 437-442, (1989)
[6]
Bowen D.T., Jacobs A., Mary P., Cotes P.M., Lewis T.C., Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes, Eur. J. Haematol., 44, pp. 30-32, (1990)
[7]
Besa E.C., Nathan F., Sylvester L., Catalano P., Erythroid response of severely anemic or transfusion-dependent patients with myelodysplastic syndrome to recombinant human erythropoietin (EPO) does not correlate with baseline serum EPO levels, Blood, 76, (1990)
[8]
Garcia J.F., Ebbe S.N., Hollander L., Cutting H.O., Miller M.E., Cronkite E.P., Radioimmunoassay of erythropoietin: circulating levels in normal and polycytemic human beings, J. Lab. Clin. Med., 99, pp. 624-635, (1982)
[9]
Schuster M.W., Allen S.L., Lichtman S.M., Schulman P., De Marco L.C., Budman D.R., Muuse W.T., The use of erythropoietin in the treatment of myelodysplastic syndrome and myelofibrosis, Proc. Am. Soc. Clin. Oncol., (1990)
[10]
Hoelzer D., Ganser A., Seipelt G., Ottman O., Hoffken K., Boogaerts M., Verhaef G., Lutz D., Krieger O., De Witte T., Diehl W., Lathan B., Ferrant A., Martiat P., Klausmann M., Ganghl D., Frisch J., Schultz G., Hemopoietic growth factors (HGF) in the treatment of patients with myelodysplastic syndromes, Proc. Am. Soc. Clin. Oncol., (1990)